Shandong Wit Dyne Health Co.,Ltd. (SHE:000915)
China · Delayed Price · Currency is CNY 19.18
-0.43 (-2.19%)
Nov 13, 2026, 3:04 PM CST
Shandong Wit Dyne Health Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
| 4,494 | 7,742 | 6,603 | 6,786 | 10,662 | 7,138 | |
Market Cap Growth | -45.97% | 17.25% | -2.69% | -36.35% | 49.38% | 30.23% |
Enterprise Value | 3,640 | 6,052 | 5,220 | 5,138 | 9,513 | 6,487 |
Last Close Price | 19.61 | 30.71 | 24.19 | 23.06 | 35.46 | 23.13 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
PE Ratio | 15.88 | 14.47 | 12.81 | 11.60 | 20.24 | 18.77 |
Forward PE | - | 13.39 | 12.55 | 10.50 | 15.95 | 14.64 |
PS Ratio | 3.05 | 3.47 | 3.09 | 2.73 | 4.55 | 3.52 |
PB Ratio | 1.26 | 1.78 | 1.50 | 1.51 | 2.63 | 2.10 |
P/TBV Ratio | 1.96 | 2.92 | 2.42 | 2.43 | 4.47 | 3.49 |
P/FCF Ratio | - | 6.33 | 7.45 | 6.04 | 9.63 | 11.23 |
P/OCF Ratio | - | 6.09 | 7.10 | 5.78 | 8.91 | 9.44 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 2.48 | 2.72 | 2.45 | 2.07 | 4.06 | 3.20 |
EV/EBITDA Ratio | 5.58 | 4.85 | 4.27 | 3.87 | 7.92 | 7.67 |
EV/EBIT Ratio | 6.21 | 5.14 | 4.55 | 4.09 | 8.39 | 8.35 |
EV/FCF Ratio | - | 4.95 | 5.89 | 4.57 | 8.60 | 10.21 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | - | - | - | - | 0.00 | - |
Debt / EBITDA Ratio | - | - | - | - | 0.01 | - |
Debt / FCF Ratio | - | - | - | - | 0.01 | - |
Net Debt / Equity Ratio | -0.53 | -0.75 | -0.70 | -0.72 | -0.69 | -0.57 |
Net Debt / EBITDA Ratio | -2.87 | -2.62 | -2.52 | -2.45 | -2.32 | -2.30 |
Net Debt / FCF Ratio | 61.72 | -2.67 | -3.47 | -2.90 | -2.52 | -3.06 |
Asset Turnover | 0.35 | 0.45 | 0.42 | 0.50 | 0.54 | 0.53 |
Inventory Turnover | 3.07 | 4.56 | 4.37 | 3.91 | 5.31 | 5.32 |
Quick Ratio | 11.81 | 6.37 | 8.13 | 6.04 | 5.67 | 5.14 |
Current Ratio | 13.03 | 6.58 | 8.40 | 6.25 | 5.89 | 5.42 |
Return on Equity (ROE) | 13.64% | 23.47% | 22.59% | 26.34% | 26.75% | 22.24% |
Return on Assets (ROA) | 8.74% | 14.82% | 14.17% | 15.88% | 16.42% | 12.73% |
Return on Invested Capital (ROIC) | 31.80% | 82.86% | 76.38% | 85.11% | 71.47% | 45.99% |
Return on Capital Employed (ROCE) | 16.30% | 26.50% | 25.50% | 27.30% | 27.30% | 22.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Earnings Yield | 6.30% | 6.91% | 7.81% | 8.62% | 4.94% | 5.33% |
FCF Yield | -0.69% | 15.80% | 13.42% | 16.56% | 10.38% | 8.90% |
Dividend Yield | 13.03% | 7.57% | 8.87% | 6.91% | 1.76% | 2.63% |
Payout Ratio | 206.64% | 109.48% | 113.62% | 31.86% | 64.47% | 27.65% |
Buyback Yield / Dilution | -0.14% | -0.14% | -0.11% | 0.02% | 0.24% | -0.11% |
Total Shareholder Return | 12.60% | 7.43% | 8.76% | 6.93% | 2.00% | 2.52% |